Menu

Lycia Therapeutics, Inc. LYCA

Full chart Compare
Set alert

Price alert · LYCA

All alert types
30.50 USD +1.70 (+5.90%)

At closeNov 6, 2026, 4:00 PM EST

30.50 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

28.91 Day range 31.18
25.05 52-week range 30.50
YTD
+1.67%
1 year
+1.67%

Revenue & Expenses

Other Income → Expenses: $4.73MExpenses → Selling, General & Admin: $6.11MExpenses → Research & Development: $40.51MExpenses → Other Operating Expenses: $1.53MExpenses → Interest Expense: $31.00KIncome Tax Benefit → Expenses: $249.00KGross Profit → Expenses: $6.74MRevenue → Gross Profit: $6.74MNet Loss → Expenses: $36.46MOther Income$4.73MIncome Tax Benefit$249.00KGross Profit$6.74MNet Loss$36.46MExpenses$48.18MSelling, General & Admin$6.11MResearch & Development$40.51MOther Operating Expenses$1.53MInterest Expense$31.00KRevenue$6.74M

Latest period ending Dec 31, 2025 · select a line to chart its full history

LYCA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
6.74M14.94M
6.74M14.94M
-41.41M-32.53M
-36.46M-26.50M
-2.59-1.98
LYCA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
19.42M30.74M
97.22M150.91M
8.21M26.50M
2.75M4.77M
-113.34M-77.93M
LYCA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
-51.36M-29.50M
39.96M-59.71M
77.00K106.42M
-159.00K-1.27M
-11.32M17.21M